A detailed history of Kennebec Savings Bank transactions in Supernus Pharmaceuticals, Inc. stock. As of the latest transaction made, Kennebec Savings Bank holds 3,300 shares of SUPN stock, worth $122,067. This represents 0.1% of its overall portfolio holdings.

Number of Shares
3,300
Holding current value
$122,067
% of portfolio
0.1%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

BUY
$25.77 - $35.16 $85,041 - $116,027
3,300 New
3,300 $103 Million

Others Institutions Holding SUPN

About SUPERNUS PHARMACEUTICALS, INC.


  • Ticker SUPN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 53,495,300
  • Market Cap $1.98B
  • Description
  • Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...
More about SUPN
Track This Portfolio

Track Kennebec Savings Bank Portfolio

Follow Kennebec Savings Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kennebec Savings Bank, based on Form 13F filings with the SEC.

News

Stay updated on Kennebec Savings Bank with notifications on news.